免疫学最新イラストレイテッド　改訂第2版

出版社： 羊土社
著者：
発行日： 2009-03-01
分野： 基礎医学  >  免疫/血清
ISBN： 9784758120012
電子書籍版： 2009-03-01 （第2版第2刷）
書籍・雑誌
≪全国送料無料でお届け≫
品切れ

5,720 円(税込)

電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

5,720 円(税込)

購入する

商品紹介

豊富なイラストで難しい免疫学がよく理解できると評判のテキスト、待望の改訂版。目まぐるしく進展する免疫学の最新知見に基づき
、全章に渡ってアップデート。分子メカニズムの詳細から臨床応用まで網羅できます。

目次

  • 免疫学最新イラストレイテッド　改訂第2版

    ―目次―

    概論　免疫系の四次元的理解を目指して

    第1章　自然免疫とToll様受容体
    第2章　免疫細胞表面受容体としてのレクチン
    第3章　補体
    第4章　B細胞の分化と機能
    第5章　T細胞の分化と機能
    第6章　抗原提示と樹状細胞
    第7章　NK細胞とNKT細胞
    第8章　リンパ系の構築
    第9章　アレルギーと自己免疫疾患
    第10章　腫瘍免疫
    第11章　感染免疫
    第12章　移植免疫

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

第1章 自然免疫とToll様受容体

P.39 掲載の参考文献
1) Janeway, C. A. Jr. & Medzhitov, R.:Innate immune recognition. Annu. Rev. Immunol., 20:197-216, 2002
PubMed
2) Akira, S. et al.:Pathogen recognition and innate immunity. Cell, 124:783-801, 2006
PubMed
3) Takeda, K. et al.:Toll-like receptors. Annu. Rev. Immunol., 21:335-376, 2003
PubMed
4) Beutler, B. et al.:Genetic analysis of resistance to viral infection. Nat. Rev. Immunol., 7:753-766, 2007
PubMed
5) Meylan, E. et al.:Intracellular pattern recognition receptors in the host response. Nature, 442:39-44, 2006
PubMed
6) Tokunaga, T. et al.:Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity. J. Natl. Cancer Inst., 72:955-962., 1984
PubMed
7) Ohto, U. et al.:Crystal structures of human MD-2 and its complex with antiendotoxic lipid IVa. Science, 316:1632-1634, 2007
PubMed
8) Delbridge, L. M. O'Riordan, M. X.:Innate recognition of intracellular bacteria. Curr. Opin. Immunol., 19:10-16, 2007
 
9) Taniguchi, T. & Takaoka A.:The interferonalpha/beta system in antiviral responses:a multimodal machinery of gene regulation by the IRF family of transcription factors. Curr. Opin. Immunol., 14:111-116, 2002
 
10) Colonna, M. et al.:Plasmacytoid dendritic cells in immunity. Nat. Immunol., 5:1219-1226, 2004
PubMed
11) Kaisho, T. & Tanaka, T.:Turning NF-kappaB and IRFs on and off in DC. Trends Immunol., 29:329-336, 2008
 
12) Ogura, Y. et al.:The inflammasome:first line of the immune response to cell stress. Cell, 126:659-662, 2006
PubMed
13) Petrilli, V. et al.:The inflammasome:a danger sensing complex triggering innate immunity. Curr. Opin. Immunol., 19:615-622, 2007
 
14) Quintana-Murci, L. et al.:Immunology in natura:clinical, epidemiological and evolutionary genetics of infectious diseases. Nat. Immunol., 8:1165-1171, 2007
PubMed
15) Gilliet, M. et al.:Plasmacytoid dendritic cells:sensing nucleic acids in viral infection and autoimmune diseases. Nat. Rev. Immunol., 8:594-606, 2008
PubMed
16) Banchereau, J. & Pascual, V.:Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity, 25:383-392, 2006
PubMed

第2章 免疫細胞表面受容体としてのレクチン

P.58 掲載の参考文献
1) Goldsten, I. J. et al.:What should be called a lectin ? Nature, 285:66, 1980
 
2) Crocker, P. R. et al.:Siglecs and their roles in the immune system. Nat. Rev. Immunol., 7:255-266, 2007
PubMed
3) Varki, N. M. & Varki, A.:Diversity in cell surface sialic acid presentations:implications for biology and disease. Lab. Invest., 87:851-857, 2007
PubMed
4) Dodd, R. B. & Drickamer, K.:Lectin-like proteins in model organisms:implications for evolution of carbohydrate-binding activity. Glycobiology, 11:71R-9R, 2001
PubMed
5) Ley, K.:The role of selectins in inflammation and disease. Trends. Mol. Med., 9:263-268, 2003
PubMed
6) Zelensky, A. N. & Gready, J. E.:The C-type lectin-like domain superfamily. FEBS J., 272:6179-6217, 2005
 
7) Rosen, S. D.:Ligands for L-selectin:homing, inflammation, and beyond. Annu. Rev. Immunol., 22:129-156, 2004
PubMed
8) Brown, G. D.:Dectin-1:a signalling non TLR patternrecognition receptor. Nat. Rev. Immunol., 6:33-43, 2006
PubMed
9) Robinson, M. J. et al.:Myeloid C-type lectins in innate immunity. Nat. Immunol., 7:1258-1265, 2006
PubMed
10) Saba, K. et al.:C-type lectin MGL1/CD301a plays an anti-inflammatory role in murine experimental colitis. Am. J. Pathol., 174:144-152, 2009
PubMed
11) Takada, A. et al.:Human macrophage C-type lectin specific for galactose and N-acetylgalactosamine promotes filovirus entry. J. Virol., 78:2943-2947, 2004
 
12) Yang, R. Y. et al:Galectins:structure, function and therapeutic potential. Expert. Rev. Mol. Med., 10:e17, 2008
PubMed
13) Hsu, D. K. & Liu, F. T.:Regulation of cellular homeostasis by galectins. Glycoconj. J., 19:507-515, 2004
 
14) Rabinovich, G. A. et al.:An emerging role for galectins in tuning the immune response:lessons from experimental models of inflammatory disease, autoimmunity and cancer. Scand. J. Immunol., 66:143-158, 2007
PubMed
15) Toscano, M. A. et al.:Dissecting the pathophysiologic role of endogenous lectins:glycan-binding proteins with cytokine-like activity? Cytokine Growth Factor Rev., 18, 57-71, 2007
PubMed
16) Rapoport, E. M. et al.:Mammalian galectins:structure, carbohydrate specificity, and functions. Biochemistry (Mosc), 73:393-405, 2008
PubMed
17) Lau, K. S. & Dennis, J. W.:N-Glycans in cancer progression. Glycobiology, 18:750-760, 2008
PubMed

第3章 補体

P.74 掲載の参考文献
1) Kishore, U. & Reid, K. M. B.:C1q:structure, function, and receptors. Immunopharmacology, 49:159-170, 2000
 
2) Fearon, D. T. & Carroll, M. C.:Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex. Annu. Rev. Immunol., 19:393-422, 2000
 
3) Fujita, T.:Evolution of the lectin-complement pathway and its role in innate immunity. Nat. Rev. Immunol., 2:346-353, 2002
PubMed
4) Parker, C. J.:Historical Review:Historical aspects of paroxysmal nocturnal haemoglobinuria:'Defining the disease'. Brit. J. Haematol., 117:3-22, 2002
 
5) Walport, M. J.:Complement:First of two parts. New Engl. J. Med., 344:1058-1066, 2001
PubMed
6) Walport, M. J.:Complement:Second of two parts. New Engl. J. Med., 344:1140-1144, 2001
PubMed

第4章 B細胞の分化と機能

P.99 掲載の参考文献
1) Kinoshita, K. & Honjo, T.:Linking class-switch recombination with somatic hypermutation. Nat. Rev. Mol. Cell. Biol., 2:493-503, 2001
PubMed
2) Chaudhuri, J. et al.:Evolution of the immunoglobulin Heavy Chain Class Switch Recombination Mechanism. Adv. Immunol., 94:157-214, 2007
PubMed
3) 烏山一: プレB細胞レセプターを解するB細胞分化誘導. 蛋白質核酸酵素増刊: 2182-2187, 2002
 
4) Meffre, E. et al.:Antibody regulation of B cell development. Nat. immunol., 1:379-385, 2000
PubMed
5) Johnson, K. et al.:B cell-specific loss of histone 3 lysine 9 methylation in the VH locus depends on Pax5. Nat. immunol., 5:853-861, 2004
 
6) Chowdhury, D. et al.:Transient IL-7/IL-7R signaling provides a mechanism for feedback inhibition of immunoglobulin heavy chain gene rearrengements. Immunity, 18:229-241, 2003
 
7) Zhang, Z. et al.:Transcription factor Pax5(BSAP) transactivates the RAG-mediated VH-to DJH rearrengement of immunoglobulin genes. Nat. immunol., 7:616-624, 2006
 
8) Kurosaki, T.:Regulation of B cell fates by BCR signaling components. Curr. Opin. Immunol., 14:341-347, 2002
PubMed
9) Fugmann, S. D. et al.:The RAG proteins and V(D)J recombination:complexes, ends, and transposition. Annu. Rev. Immunol., 18:495-527, 2000
PubMed
10) Kurosaki, T.:Checks and balances on developing B cells. Nat. Immunol., 4:13-15, 2003
PubMed
11) Fagarasan, S. & Honjo, T.:T-independent Immune response:new aspects of B cell biology. Science, 290:89-92, 2000
PubMed
12) Hardy, R. R. & Hayakawa, K.:B cell development pathways. Annu. Rev. Immunol., 19:595-621, 2001
 
13) Martin, F. & Kearney, J. F.:Marginal-zone B cells. Nat. Rev. Immunol., 2:323-335, 2002
 
14) Cariappa, A. & Pillai, S.:Antigen-dependent B-cell development. Curr. Opin. Immunol., 14:241-249, 2002
PubMed
15) Mackay, F. & Browning, J. L.:BAFF:A fundamental survival factor for B cells. Nat. Rev. Immunol., 2:465-475, 2002
PubMed
16) Ansel, K. M. et al.:A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature, 406:309-314, 2000
PubMed
17) Lu, T. T. & Cyster, J. G.:Integrin-mediated long-term B cell retention in the splenic marginal zone. Science, 297:409-412, 2002
PubMed
18) Guinamard, R. et al.:Absence of marginal zone B cells in Pyk-2-deficient mice defines their role in the humoral response. Nat. Immunol., 1:31-36, 2000
 
19) Ansel, K. M. et al.:CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity. Immunity, 16:67-76, 2002
PubMed
20) Nemazee, D.:Receptor selection in B and T lymphocytes. Annu. Rev. Immunol., 18:19-51, 2000
 
21) Healy, J. I. & Goodnow, C. C.:Positive versus negative signaling by lymphocyte antigen receptors. Annu. Rev. Immunol., 16:645-670, 1998
PubMed
22) Amin, R. H. et al.:Foxo1 directly regulates the transcription of recombination-activating genes during B cell development. Nat. Immunol., 9:613-622, 2008
 
23) Herzog, S. et al.:SLP-65 regulates immunoglobulin light chain gene recombination through the PI(3)K-PKB-Foxo pathway. Nat. Immunol., 9:623-631, 2008
PubMed
24) Lam, K-P. et al.:In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell, 90:1073-1083, 1997
PubMed
25) Hayakawa, K. et al.:Positive selection of natural autoreactive B cells. Science, 285:113-116
 
26) Kurosaki, T.:Genetic analysis of B cell antigen receptor signaling. Annu. Rev. Immunol., 17:555-592, 1999
PubMed
27) Kurosaki, T.:Regulation of B-cell signal transduction by adaptor proteins. Nat. Rev. immunol., 2:354-363, 2002
PubMed
28) Kurosaki, T. et al.:B cell signaling and fate decision. Annu. Rev. Immunol.:2009
 
29) Reif, K. et al.:Balanced responsiveness to chemoattractants from adjacent zones determines B-cell position. Nature, 416:94-99, 2002
PubMed
30) Fu, Y-X. & Chaplin, D. D.:Development and maturation of secondary lymphoid tissues. Annu. Rev. Immunol., 17:399-433, 1999
PubMed
31) 徳久剛史: 免疫記憶細胞分化におけるBc16の機能. 蛋白質核酸酵素増刊: 2306-2312, 2002
 
32) 竹森利忠: メモリーB細胞の産生と維持の制御. 蛋白質核酸酵素増刊: 2293-2299, 2002
 
33) Obukhanych, T. V. et al. T-independent type II immune responses generate memory B cells. J. Exp. Med., 203:305-310, 2006
PubMed

第5章 T細胞の分化と機能

P.118 掲載の参考文献
1) Murphy, K. M. et al.:"Janeway's Immunobiology. 7th edition." Garland Science, 2007
 
2) Starr, T. K. et al.:Positive and negative selection of T cells. Annu. Rev. Immunol., 21:139-176, 2003
PubMed
3) von Boehmer, H.:Selection of the T-cell repertoire:receptor-controlled checkpoints in T-cell development. Adv. Immunol., 84:201-238, 2004
 
4) Takahama, Y.:Journey through the thymus:stromal guides for T-cell development and selection. Nat. Rev. Immunol., 6:127-135, 2006
 
5)Takahama, Y. et al.:Modest cortex and promiscuous medulla for thymic repertoire formation. Trends Immunol., 29:251-255, 2008
PubMed
6) Kyewski, B. & Klein, L.:A central role for central tolerance. Annu. Rev. Immunol., 24:571-606, 2006
 
7) Anderson, G. et al.:Generating intrathymic microenvironments to establish T-cell tolerance. Nat. Rev. Immunol., 7:954-963, 2007
PubMed
8) Singer, A. et al.:Lineage fate and intense debate:myths, models and mechanisms of CD4-versus CD8-lineage choice. Nat. Rev. Immunol., 8:788-801, 2008
PubMed
9) Zhu, J. & Paul, W. E.:CD4 T cells:fates, functions, and faults. Blood, 112:1557-1569, 2008
PubMed
10) Sakaguchi, S.:Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol., 6:345-352, 2005
PubMed

第6章 抗原提示と樹状細胞

P.144 掲載の参考文献
1) Shortman, K. & Liu, Y. J.:Mouse and human dendritic cell subtypes. Nat. Rev. Immunol., 2:151-161, 2002
PubMed
2) Colonna, M. et al.:Interferon-producing cells:on the front line in immune responses against pathogens. Curr. Opin. Immunol., 14:373-379, 2002
PubMed
3) Figdor, C. G. et al.:C-type lectin receptors on dendritic cells and Langerhans cells. Nat. Rev. Immunol., 2:77-84, 2002
PubMed
4) Caux, C. et al.:Regulation of dendritic cell recruitment by chemokines. Transplantation, 73:S7-S11, 2002
PubMed
5) Guermonprez, P. et al.:Antigen presentation and T cell stimulation by dendritic cells. Annu. Rev. Immunol., 20:621-667, 2002
 
6) Nobes, C. & Marsh, M.:Dendritic cells:new roles for Cdc42 and Rac in antigen uptake? Curr. Biol., 10:R739-741, 2000
PubMed
7) Cresswell, P. et al.:Thiol oxidation and reduction in MHC=restricted antigen processing and presentation. Immunol. Res., 19:191-200, 1999
 
8) Ting, J. P. & Trowsdale, J.:Genetic control of MHC class II expression. Cell, 109(Suppl. ):S21-33, 2002
 
9) Villadangos, J. A. & Ploegh, H. L.:Proteolysis in MHC class II antigen presentation:who's in charge? Immunity, 12:233-239, 2000
PubMed
10) Elizabeth, M. et al.:Trafficking of MHC class II molecules in the late secretory pathway. Curr. Opin. Immunol., 14:30-35, 2002
 
11) Mellman, I. & Steinman, R. M.:Dendritic cells:specialized and regulated antigen processing machines. Cell, 106:255-258, 2001
PubMed
12) Yewdell, J. W. & Tscharke, D. C.:Inside the professionals. Nature, 418:923-924, 2002
PubMed
13) Gromme, M. & Neefjes, J.:Antigen degradation or presentation by MHC class I molecules via classical and non-classical pathways. Mol. Immunol., 39:181-202, 2002
 
14) Grandea, A. G. 3rd & Van, Kaer, L.:Tapasin:an ER chaperone that controls MHC class I assembly with peptide. Trends. Immunol., 22:194-199, 2001
PubMed
15)Yewdell, J. W. et al.:At the crossroads of cell biology and immunology:DRiPs and other sources of peptide ligands for MHC class I molecules. J. Cell Sci., 114:845-851, 2001
PubMed
16) Kessler, B. M. et al.:MHC class I antigen processing regulated by cytosolic proteolysis=short cuts that alterpeptide generation. Mol. Immunol., 39:171-179, 2002
PubMed
17) Murata, S. et al.:Regulation of CD8+T cell development by thymus-specific proteasomes. Science, 316:1349-1352, 2007
PubMed
18) Heath, W. R. & Carbone, F. R.:Cross-presentation in viral immunity and self-tolerance. Nat. Rev. Immunol., 1:126-134, 2001
PubMed
19) Steinman, R. M. & Nussenzweig, M. C.:Avoiding horror autotoxicus:the importance of dendritic cells in peripheral T cell tolerance. Proc. Natl. Acad. Sci. USA, 99:351-358, 2002
PubMed
20) Li, Z. et al.:P. Roles of heat-shock proteins in antigen presentation and cross-presentation. Curr. Opin. Immunol., 14:45-51, 2002
 
21) Mahnke, K. et al.:Immature, but not inactive:the tolerogenic function of immature dendritic cells. Immunol. Cell Biol., 80:477-483, 2002
 
22) Mellor, A. L. & Munn, D. H.:Tryptophan catabolism and T-cell tolerance:immunosuppression by starvation? Immunol. Today, 20:469-473, 1999
 
23) Munz, C. et al.:Dendritic cell maturation by innate lymphocytes:coordinated stimulation of innate and adaptive immunity. J. Exp. Med., 202:203-207, 2005
PubMed
24) Fujii, S. et al.:Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein. J. Exp. Med., 198:267-279, 2003
 
25) Yamaguchi, T. et al.:Control of immune responses by antigen-specific regulatory T cells expressing the folate receptor. Immunity, 27:1-5, 2007
PubMed
26) Collison, L. W. et al.:The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature, 450:566-569, 2007
PubMed
27) Loser, K. et al.:Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells. Nature Med., 12:1372-1379, 2006
PubMed
28) Wakkach, A. et al.:Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity, 18:605-617, 2003
 
29) Sato, K. et al.:Modified myeloid dendritic cells act as regulatory dendritic cells to induce anergic and regulatory T cells. Blood, 101:3581-3589, 2003
PubMed

第7章 NK細胞とNKT細胞

P.160 掲載の参考文献
1) MacDonald, H. R.:Development and selection of NKT cells. Curr. Opin. Immunol., 14:250-254, 2002
PubMed
2) Tupin, E. et al.:The unique role of natural killer T cells in the response to microorganisms. Nat. Rev. Microbiol., 5:405-417 2007
PubMed
3) Karlhofer, F. M. et al.:MHC class I alloantigen specificity of Ly-49 + IL-2-activated natural killer cells. Nature, 358:66-70, 1992
 
4) Lanier, L. L.:Up on the tightrope:natural killer cell activation and inhibition. Nat. Immunol., 9:495-502 2008
PubMed
5) Lanier, L. L.:On guard-activating NK cell receptors. Nat. Immunol., 2:23-27, 2001
PubMed
6) Gilfillan, S. et al.:NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation. Nat. Immunol., 3:1150-1155, 2002
PubMed
7) Biron, C. A. et al.:Severe herpesvirus infections in an adolescent without natural killer cells. N. Eng. J. Med., 320:1731-1735, 1989
 
8) Arase, H. et al.:Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science, 296:1323-1326, 2002
PubMed
9) Orange, J. S. et al.:Viral evasion of natural killer cells. Nat. Immunol., 3:1006-1012, 2002
PubMed
10) Diefenbach, A. et al.:Innate immune recognition by stimulatory immunoreceptors. Curr. Opin. Immunol., 15:37-44, 2003
PubMed
11) Terme, M. et al.:Natural killer cell-directed therapies:moving from unexpected results to successful strategies. Nat. Immunol., 9:486-494 2008
PubMed
12) Bix, M. et al.:Rejection of class I MHC-deficient haemopoietic cells by irradiated MHC-matched mice. Nature, 349:329-331, 1991
PubMed
13) Kawano, T. et al.:CD1d-restricted and TCR-mediated activation of V α 14 NKT cells by glycosylceramides. Science, 268:1626-1629, 1997
 
14) Mattner, J. et al.:Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature, 434, 525-529 2005
PubMed
15) Taniguchi, M. et al.:The NKT cell system:bridging innate and acquired immunity. Nat. Immunol., 4:1164-1165 2003
PubMed
16) Cui, J. et al.:Requirement for V α 14 NKT cells in IL-12-mediated rejection of tumors. Science, 278:1623-1626, 1997
 
17) Smyth, M. J. et al.:NKT cells-conductors of tumor immunity? Curr. Opin. Immunol., 14:165-171, 2002
PubMed
18) Wilson, S. B. et al.:Extreme Th1 bias of invariant V α 24J α Q T cells in type 1 diabetes. Nature, 391:177-181, 1998
 
19) Miyamoto, K. et al.:A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature, 413:531-534, 2001
PubMed
20) Crispe, I. N.:Hepatic T cells and liver tolerance. Nat. Rev. Immunol., 3:51-62, 2003
PubMed

第8章 リンパ系の構築

P.175 掲載の参考文献
1) Muller, G. & Lipp, M.:Concerted action of the chemokine and lymphotoxin system in secondary lymphoid-organ development. Curr. Opin. Immunol., 15:217-224, 2003
PubMed
2) Kiyono, H. et al.:The mucosal immune system. "Fundamental Immunology", Paul W. E. ed., (Lippincott-Raven, Philadelphia, Vol. 6, pp. 983-1030, 2008
 
3) Owen, R. L:& Jones, A. L.:Epithelial cell specialization within human Peyer's patches:an ultrastructural study of intestinal lymphoid follicles. Gastroenterology, 66:189-203, 1974
PubMed
4) Iwasaki, A. & Kelsall, B. L.:Localization of distinct Peyer's patch dendritic cell subsets and their recruitment by chemokines macrophage inflammatory protein (MIP)-3 α, MIP-3 β, and secondary lymphoid organ chemokine. J. Exp. Med., 191:1381-1394, 2000
 
5) Butcher, E. C. et al.:Surface phenotype of Peyer's patch germinal center cells:implications for the role of germinal centers in B cell differentiation. J. Immunol., 129:2698-2707, 1982
 
6) Kiyono, H. & Fukuyama, S.:NALT-versus Peyer's-patch-mediated mucosal immunity. Nat. Rev. Immunol., 4:699-710, 2004
PubMed
7) Mostov, K. E. & Deitcher, D. L.:Polymeric immunoglobulin receptor expressed in MDCK cells transcytoses IgA. Cell, 46:613-621, 1986
PubMed
8) Kunisawa, J. & Kiyono, H.:A marvel of mucosal T cells and secretory antibodies for the creation of first lines of defense. Cell Mol. Life Sci., 62:1308-1321, 2005
PubMed
9) He, B. et al.:Intestinal bacteria trigger T cell-independent immunoglobulin A2 class switching by inducing epithelial-cell secretion of the cytokine APRIL. Immunity, 26:812-826, 2007
 
10) Tsuji, M. et al.:Requirement for lymphoid tissueinducer cells in isolated follicle formation and T cellindependent immunoglobulin A generation in the gut. Immunity, 2008
 
11) Hamada, H. et al.:Identification of multiple isolated lymphoid follicles on the antimesenteric wall of the mouse small intestine. J. Immunol., 168:57-64, 2002
PubMed
12) Cerutti, A.:The regulation of IgA class switching. Nat. Rev. Immunol., 8:421-434, 2008
PubMed
13) Bettelli, E. et al.:Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature, 441:235-238, 2006
PubMed
14) Mangan, P. R. et al.:Transforming growth factor-beta induces development of the Th17 lineage. Nature, 441:231-234, 2006
PubMed
15) Benson, M. J. et al.:All-trans retinoic acid mediates enhanced Treg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. J. Exp. Med., 204:1765-1774, 2007
PubMed
16) Coombes, J. L. et al.:A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-β and retinoic acid-dependent mechanism. J. Exp. Med., 204:1757-1764, 2007
 
17) Mucida, D. et al.:Reciprocal Th17 and regulatory T cell differentiation mediated by retinoic acid. Science, 317:256-260, 2007
PubMed
18) Sun, C. M. et al.:Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 Treg cells via retinoic acid. J. Exp. Med., 204:1775-1785, 2007
PubMed
19) McGeachy, M. J. et al.:TGF β and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain Th17 cell-mediated pathology. Nat. Immunol., 8:1390-1397, 2007
 
20) Awasthi, A. et al.:A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat. Immunol., 8:1380-1389, 2007
 
21) Stumhofer, J. S. et al:Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat. Immunol., 8:1363-1371, 2007
PubMed
22) Marc, V. et al.:Transforming growth factor-β "reprograms" the differentiation of T helper 2 cells and promotes an interlenkin 9-producing subset. Nat. Immunol. 9:1341-1346, 2008
 
23) Valerie, D. et al.:IL-4 inhibits TGF-β-induced Foxp3+ T cella and, together with TGF-β, generates IL-9+ IL-10+ Foxp3- effector T cells Nat. Immunol. 9:1347-1355, 2008
 
24) Berlin, C. et al.:α 4 β 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell, 74:185-195, 1993
 
25) Cyster, J. G.:Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs. Annu. Rev. Immunol., 23:127-159, 2005
PubMed
26) Matloubian, M. et al.:Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature, 427:355-360, 2004
PubMed
27) Gohda, M. et al.:Sphingosine 1-phosphate regulates the egress of IgA plasmablasts from Peyer's patches for intestinal IgA responses. J. Immunol., 180:5335-5343, 2008
PubMed
28) Iwata, M. et al.:Retinoic acid imprints gut-homing specificity on T cells. Immunity, 21:527-538, 2004
 
29) Mora, J. R. et al.:Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells. Science, 314:1157-1160, 2006
PubMed
30) Sigmundsdottir, H. et al.:DCs metabolize sunlightinduced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27. Nat. Immunol., 8:285-293, 2007
 
31) Kunisawa, J. et al.:"Mucosal S-IgA enhancement:development of safe and effective mucosal adjuvants and mucosal antigen delivery vehicles" Kluwer Academic/Plenum Publishers, New York, 2007
 
32) Ley, R. E. et al.:Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell, 124:837-848, 2006
PubMed
33) Macpherson, A. J. & Slack, E.:The functional interactions of commensal bacteria with intestinal secretory IgA. Curr. Opin. Gastroenterol., 23:673-678, 2007
PubMed
34) Pedron, T. & Sansonetti, P.:Commensals, bacterial pathogens and intestinal inflammation:an intriguing menage a trois. Cell Host Microbe., 3:344-347, 2008
 
35) Bischoff, S. & Crowe, S. E.:Food allergy and the gastrointestinal tract. Curr. Opin. Gastroenterol., 20:156-161, 2004
PubMed
36) Rakoff-Nahoum, S. et al.:Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell, 118:229-241, 2004
PubMed
37) Bashir, M. E. et al.:Toll-like receptor 4 signaling by intestinal microbes influences susceptibility to food allergy. J. Immunol., 172:6978-6987, 2004
PubMed

第9章 アレルギーと自己免疫疾患

P.199 掲載の参考文献
1) Broide, D. H.:Molecular and cellular mechanisms of allergic diseases. J. Allergy. Clin. Immunol., 108:S65-71, 2001
PubMed
2) Galli, S. J.:Complexity and redundancy in the pathogenesis of asthma:reassessing the roles of mast cells and T cells. J. Exp. Med., 186:343-347, 1997
 
3) Oettgen, H. C. & Geha, R. S.:IgE in asthma and atopy:cellular and molecular connections. J. Clin. Invest., 104:829-835, 1999
PubMed
4) Romagnani, S.:The role of lymphocytes in allergic disease. J. Allergy. Clin. Immunol., 105:399-408, 2000
 
5) Marsh, K. C. & Marsh, D. G.:The genetics and complexity of asthma. Immunol. Today, 19:325-332, 1998
 
6) Tan, E. M.:Autoantibodies in pathology and cell biology. Cell, 67:841-842, 1991
PubMed
7) Goodnow, C. C.:Balancing immunity and toleranc:deleting and tuning lymphocyte repertoires. Proc. Natl. Acad. Sci. USA, 93:2264-2271, 1996
 
8) Shevach, E. M.:Regulatory T cells in autoimmmunity. Annu. Rev. Immunol., 18:423-449, 2000
PubMed
9) Encinas, J. A. & Kuchroo, V. K.:Mapping and identification of autoimmunity genes. Curr. Opin. Immunol., 12:691-697, 2000
PubMed
10) Kalden, J. R. et al.:Immunological treatment of autoimmune diseases. Adv. Immunol., 68:333-418, 1998
PubMed

第10章 腫瘍免疫

P.234 掲載の参考文献
1) Fujiwara, H, & Hamaoka, T.:Coordination of chemokine and adhesion systems in intratumoral T cell migration responsible for the induction of tumor regression. Int. Immunopharmacol., 1:613-623, 2001
PubMed
2) Nakajima, C. et al.:A role of interferon-gamma (IFN-gamma)in tumor immunity:T cells with the capacity to reject tumor cells are generated but fail to migrate to tumor sites in INF-gamma-deficient mice. Cancer Res., 61:3399-3405, 2001
 
3) Murata, Y. et al:Sequential conversion of the redox status of macrophages dictates the pathological ptopression of autoimmune diabetes. Eur. J. Immunol., 33:1001-1011, 2003
PubMed
4) Zhao, W. et al.:Hypoxia suppresses the production of matrix metalloproteinases and the migration of human monocyte-derived dendric cells. Eur. J. Immunol., 35:2468-3477, 2005
 
5) Gallimore, A. & Sakaguchi, S.:Regelation of tumour immunity by CD25+T cells. Immunology, 107:5-9, 2002
 
6) Seki, E. et al.:TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat. Med., 13:1324-1332. 2007
PubMed
7) Murata, Y. et al.:IFN-gamma end pro-inflammatory cytokine production by antigen-presenting cells is dictated by intracellular thiol redox status regulated by oxygen tension. Eur. J. Immunol., 2866-2873, 2002
 
8) Murdoch, C. et al.:The role of myeloid cells in the promotion of tumour angiogenesis. Nat. Rev. Cancer, 8:618-31, 2008
PubMed
9) Ben-Neriah, Y. & Schmidt-Supprian M.:Epithelial NF-kappaB maintains host gut microflora homeostasis. Nat. Immunol., 8:479-481, 2007
PubMed
10) Tacken, P. J. et al.:Dendritic-cell immunotherapy:from ex vivo loading to in vivo targeting. Nat. Rev. Immunol., 7:790-802, 2007
PubMed
11) Kuwajima, S. et al.:Interleukin 15-dependent crosstalk between conventional and plasmacytoiddendritic cells is essential for CpG-induced immune activation. Nat. Immunol., 7:740-746, 2006
 
12) Chan, C. W. & Housseau, F.:The 'kiss of death' by dendritic cells to cancer cells. Cell Death Differ., 15:58-69, 2008
PubMed
13) Melero, I. et al.:Immunostimulatory monoclonal antibodies for cancer therapy. Nat. Rev. Cancer, 7:95-106, 2007
PubMed
14) Vaupel, P. et al.:Treatment resistance of solid tumors:role of hypoxia and anemia. Med. Oncol., 18:243-259, 2001
PubMed
15) Adam, M. F. et al:Tissue oxygen distribution in head. and neck cancer patients. Head Neck, 21 146-153, 1999
PubMed
・Murata, Y. et al.: The polarization of T(h)1/T(h)2 balance is dependent on the intracellular thiol redox status of macrophages due to the distinctive cytokine production. Int Immunol., 14 : 201-212, 2002
 
・羽室淳爾: "生体防御と癌", 講談社サイエンティフィック, 東京, 1994
 
・Dendritic cell biologyと臨床応用への展望. Biotherapy, 14(12): 2000
 
・Th1/Th2バランス異常と疾患. Molecular Medicine, 38(12): 2001
 
・Tisdale, M. J.: cachexia in cancer patients. Nat. Rev. Cancer, 2 : 862-871, 2002
PubMed
・Gordon, S.: Alternative activation of macrophages. Nat. Rev. Immunol., 3 : 23-35, 2003
PubMed
・羽室淳爾, 村田幸恵: "異物識別と生体反応(岡田秀親/編)", '癌免疫療法の展望: 癌局所炎症反応とMφのレドックス機能', pp287-325, 采根出版, 東京, 1998
 
・藤原大美: "腫瘍免疫学", 中外医学社, 東京, 1998
 
・免疫でいかに癌を叩くか. Mebio, 13(11): 1996
 
・免疫系は癌細胞を拒絶できるか. 細胞工学, 8: 1998
 
・池田英之, 佐藤昇志: 腫瘍特異抗原としてのCancer-testis(CT)抗原. Ann. Rev. 免疫2001: 317-327, 2000
 
・榧垣伸彦, 他: Immunology Frontier, 11: 191-198, 2001
Medical*Online
・腫瘍免疫の阻害要因とその機序. 臨床免疫, 29(1): 1997
 
・黒木登志夫: "癌細胞の誕生", 朝日選書, 朝日新聞社, 東京, 1989
 

第11章 感染免疫

P.256 掲載の参考文献
1) Aderem, A. & Underhill, D. M.:Mechanisms of phagocytosis in macrophages. Annu. Rev. Immunol., 17:593-623, 1999
PubMed
2) Finlay, B. B. & McFadden, G.:Anti-immunology:evasion of the host immune system by bacterial and viral pathogens. Cell, 124:767-782, 2006
PubMed
3) Zlotnik, A. & Yoshie, A.:Chemokines:a new classification system and their role in immunity. Immunity, 12:121-127, 2000
 
4) Menendez, A. Brett & Finlay, B.:Defensins in the immunology of bacterial infections. Curr. Opin. Immunol., 19:385-391, 2007
 
5) Ishii, K. J. et al.:Host innate immune receptors and beyond:making sense of microbial infections. Cell Host Microbe., 3:352-363, 2008
PubMed
6) Szabo, G. & Dolganiuc, A.:The role of plasmacytoid dendritic cell-derived IFN alpha in antiviral immunity. Crit. Rev. Immunol., 28:61-94, 2008
PubMed
7) Vivier, E. et al.:Functions of natural killer cells. Nat. Immunol., 9:503-510, 2008
PubMed
8) Hayday, A. & Tigelaar, R.:Immunoregulation in the tissues by gammadelta T cells. Nat. Rev. Immunol., 3:233-242, 2003
PubMed
9) Tupin, E. et al.:The unique role of natural killer T cells in the response to microorganisms. Nat. Rev. Microbiol., 5:405-417., 2007
PubMed
10) Berg, L. J.:Signalling through TEC kinases regulates conventional versus innate CD8(+)T-cell development. Nat. Rev. Immunol., 7:479-485, 2007
PubMed
11) Hardy, R. R.:B-1 B cells:development, selection, natural autoantibody and leukemia. Curr. Opin. Immunol., 18:547-555, 2006
PubMed
12) Dong, C.:TH17 cells in development:an updated view of their molecular identity and genetic programming. Nat. Rev. Immunol., 8:337-348, 2008
PubMed
13) Seder, R. A. et al.:T-cell quality in memory and protection:implications for vaccine design. Nat. Rev. Immunol., 8:247-258, 2008
PubMed
14) Sakaguchi, S. et al.:Regulatory T cells and immune tolerance. Cell, 133:775-787, 2008
PubMed
15) 中山哲夫: ワクチン. 日本臨床, 66: 1851-1857, 2008
Medical*Online

第12章 移植免疫

P.284 掲載の参考文献
1) Spier, J. A. et al.:Structural basis of 2C TCR allorecognition of H-2Ld peptide complexes. Immunity, 8:553-562, 1998
 
2) Reiser, J-B. et al.:Crystal structure of a T cell receptor bound to an allogeneic MHC molecule. Nat. Immunol., 4:291-297, 2000
 
3) Rudolph, M. G. et al.:The crystal structures of Kbm1 and Kbm8 reveal that subtle changes in the peptide environment impact thermostability and alloreactivity Immunity, 14:231-242, 2001
PubMed
4) Luz, J. G. et al.:Structural comaparison of allogeneic and syngeneic T cell receptor-peptide-major histocompatibikity complex complexes:a buried alloreactive mutation subtly alters peptide presentation substantially increasing Vβ interactions. J. Exp. Med., 195:1175-1186, 2002
 
5) Hennecke J. & Wiley D. C.:Structure of a complex of the human α/β T cell recptor(TCR) HA1.7, influenza hemagglutinin peptide, and major histocompatibility complex class II molecule, HLA-DR4 (DRA*0101 and DRB1*0401):Insight into TCR crossrestriction and alloreactivity. J. Exp. Med., 195:571-581, 2002
 
6) Annual progress report from the Japanese renal transplant registry. The number of the renal transplantation in 2006. Japan J. Transplant, 42:47-52, 2007
 
7) 田所憲治, 十字猛夫: 輸血後GVHD. 日本臨床, 60 suppl. 1: 724-731, 2002
 
8) 森島泰雄: 造血幹細胞移植におけるNKレセプターとHLAの適合性. 臨床免疫・アレルギー科, 50: 98-107, 2008
 
9) Kawase, T, et al.:High-risk HLA allele mismatch combinations responsible for severe acute graft-versus-host disease and implication for its molecular mechanism. Blood, 110:2235-2242, 2007
PubMed
10) Farag, S. S. et al.:The effect of KIR liand incompatibility on the outcome of unrelated donor transplantation:A report from the Center for International Blood and Marrow Transplant Research, the European Blood and Marrow Transplant Registry, and the Dutch Registry. Biol. Blood Marrow Transplant., 12:876-884, 2006
 
11) van Bergen, C. et al.:Multiple myeloma reactive T cells recognize an activation induced minor histocompatibility antigen encoded by the ATP dependent interferon responsive(ADIR)gene. Blood, 109:4089-4096, 2007
PubMed
12) Akatsuka, Y. et al.:Minor histocompatibility antigens as targets for immunotherapy using allogeneic immune reactions. Cancer Sci., 98:1139-1146, 2007
PubMed
13) Goulmy, E. et al.:Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. N. Engl. J. Med., 334:281-285, 1996
PubMed
14) Horowitz, M. M. et al.:Graft-versus-leukemia reactions after bone marrow transplantation. Blood, 75:555-562, 1990
PubMed
15) Campbell, J. D. M. et al.:Evolution of bone marrow transplantation the original immunotherapy. Trends Immunol., 22:88-92, 2001
 
16) Childs, R. et al.:Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation. N. Engl. J. Med., 343:750-758, 2000
PubMed
17) Demirer, T. et al.:Transplantation of allogeneic hematopoietic stem cells:an emerging treatment modality for solid tumors. Nat. Clinical Practice Oncology, 5:256-267, 2008
 
18) van Rood, J. J.:On the clinical importance of Privileged sites. Hum. Immunol., 63:799-804, 2002
PubMed
19) McKenna, R. M. et al.:Anti-HLA antibodies after solid organ transplantation. Transplantation, 69:319-326, 2000
PubMed
20) Lee, P. C. et al.:All chronic rejection failures of kidney transplants preceded by development of HLA antibodies. Transplantation, 74:1192-1194, 2002
PubMed
21) Lederer, S. R. et al.:Impact of humoral alloreactivity early after transplantation on the long-term survival of renal allografts. Kidney Int., 59:334-341, 2001
 
22) Terasaki, P. & Mizutani, K.:Antibody Mediated Rejection:Update 2006. Clin. J. Am. Soc. Nephrol. 1:400-403, 2006
PubMed
23) Logan, J. S.:Prospect for xenotransplantation. Curr. Opin. Immunol., 12:563-568, 2000
PubMed
24) Sprangers, B. et al.:Xenotransplantation:Where are we in 2008? Kidney International, 74:14-21, 2008
PubMed
25) Lai, L. et al.:production of a-1, 3-galactosyltransferase knock out pigs by nuclear transfer cloning. Science, 295:1089-1092, 2002
PubMed
26) Jordan, S. C. et al.:Intravenous gammaglobulin (IVIG):a novel approach to improve transplant rates and outcomes in highly HLA-sensitized patients. Am. J. Transplant., 6:459-466, 2006
PubMed
27) Vieira, C. A. et al.:Rituximab for reduction of anti-HLA antibodies in patients awaiting renal transplantation:safety, pharmacodynamics, and pharmacokinetics. Transplantation, 77:542-548, 2004
PubMed
28) Ramos, E. J. et al.:The effect of desensitization protocols on human splenic B-cell population in vivo. Am. J. Transplant., 7:402-407, 2007
PubMed
29) Becker, Y. T. et al.:The emerging role of rituximab in organ transplantation. Transplant International, 19:621-628, 2006
 
30) Ashley, A. et al.:Rituximab and intravenous immune globulin for desensitization during renal transplantation. N. Engl. J. Med., 359:242-251, 2008
 
31) Pittenger. M. F. et al.:Multilineage potential of adult human mesenchymal stem cells. Science, 284:143-147, 1999
PubMed
32) Thomson, J. A. et al.:Embryonic stem cell lines derived from human blastocysts. Science, 282:1145-1147. 1998
PubMed
33) Murry, C. E. & keller, G.:Differentiation of embryonic stem cells to clinically relevant populations:lessons from embryonic development, Cell, 132:661-680, 2008
PubMed
34) Wakayama, T. et al.:Differentiation of embryonic stem cell lines generated from adult somatic cells by nuclear transfer. Science, 292:740-743, 2001
PubMed
35) Takahashi, K. & Yamanaka, S.:Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126:663-676, 2006
PubMed
36) Takahashi, K. et al.:Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131:861-872, 2007
PubMed
37) Yu, J. et al.:Induced pluripotent stem cell lines derived from human somatic cells. Science, 318:1917-1920, 2007
PubMed
38) Park, I. H. et al.:Reprogramming of human somatic cells to pluripotency with defined factors. Nature, 451:141-146, 2007
PubMed
39) Liu, S. V. iPS cells:A more critical review. Stem Cells Dev., 17:391-397, 2008
PubMed
40) Nakatsuji, N. et al.:HLA-haplotype banking and iPS cells. Nat. Biotechnol., 26:739-740, 2008
PubMed
41) Shi, Y. et al. A Combined chemical and genetic approach for the generation of induced pluripotent stem cells. Cell Stem Cell, 2:525-528, 2008
 

書評

最近チェックした商品履歴

Loading...